Antibacterial agents which specifically inhibit CTP:CMP-3-deoxy-D-manno-octulosonate cytidylyltransferase activity were used to block the incorporation of 3-deoxy-D-manno-octulosonate (KDO) into lipopolysaccharide. Lipopolysaccharide synthesis ceased, molecules similar in structure to lipid A accumulated, and bacterial growth ceased following addition of such agents to cultures of SalmoneUa typhimurium and Escherichia coli. Although four major species of lipid A accumulated in S. typhimurium, their kinetics of accumulation were different. The least polar of the major species was WVA [0-(2-amino-2-deoxy-(-D-glucopyranosyl)-(1-÷6)-2-amino-2-deoxy-a-o-glucose, acylated at positions 2, 3, 2', and 3' with ,-hydroxymyristoyl groups and bearing phosphates at positions 1 and 4'J, a molecule previously isolated from bacteria containing a kdsA mutation (C. R. H. Raetz, S. Purcell, M. V. Meyer, N. Qureshi, and K. Takayama, J. Biol. Chem. 260:16080-16088, 1985). Species IVA accumulated first and to the greatest extent following addition of the inhibitor, with other more polar derivatives appearing only after 'VA attained half its maximal level. In contrast, only two major species of precursor accumulated in E. cohi following addition of the inhibitor. One of these species was identical to WA from S. typhimurium on the basis of chemical composition, fast atom bombardment mass spectroscopy, and comigration on Silica Gel H, and it also accumulated prior to a more polar species of related structure. We conclude that the addition of KDO to precursor species 'VA is the major pathway of lipid A-KDO formation in both S. typhimurium LT2 and E. coli and that accumulation of the more polar species lacking KDO only occurs in response to accumulation of species 'VA following inhibition of the normal pathway.
amino-2-deoxy-a-o-glucose, acylated at positions 2, 3, 2', and 3' with ,-hydroxymyristoyl groups and bearing phosphates at positions 1 and 4'J, a molecule previously isolated from bacteria containing a kdsA mutation (C. R. H. Raetz, S. Purcell, M. V. Meyer, N. Qureshi, and K. Takayama, J. Biol. Chem. 260: [16080] [16081] [16082] [16083] [16084] [16085] [16086] [16087] [16088] 1985) . Species IVA accumulated first and to the greatest extent following addition of the inhibitor, with other more polar derivatives appearing only after 'VA attained half its maximal level. In contrast, only two major species of precursor accumulated in E. cohi following addition of the inhibitor. One of these species was identical to WA from S. typhimurium on the basis of chemical composition, fast atom bombardment mass spectroscopy, and comigration on Silica Gel H, and it also accumulated prior to a more polar species of related structure. We conclude that the addition of KDO to precursor species 'VA is the major pathway of lipid A-KDO formation in both S. typhimurium LT2 and E. coli and that accumulation of the more polar species lacking KDO only occurs in response to accumulation of species 'VA following inhibition of the normal pathway.
The study of the early steps in lipopolysaccharide (LPS) synthesis has been limited to biochemical analysis of mutants blocked in the pathway (1, 7, 12, 15, 20, 22) or direct biochemical analysis of the flow of metabolites in normal bacteria (1, 20, 21) . The study of mutants is limited by the lack of direct methods for selecting mutants blocked early in the pathway, while the direct biochemical approach, which itself often begins with the analysis of mutants, can be very difficult because intermediates in the pathway are present in low amounts and subject to rapid turnover (1) . The use of specific metabolic inhibitors is a third approach to studying metabolic pathways, one which has only recently been available for the study of LPS synthesis in gram-negative bacteria (5) .
In the absence of direct methods for selecting mutants defective in the early steps of LPS synthesis, inventive approaches to enriching for such mutants have been developed (6, 11, 23, 24) . These methods have thus far only yielded mutants defective in the 3-deoxy-D-manno-octulosonate (KDO) pathway. Such mutants proved invaluable in studying specific aspects of LPS synthesis at the level of KDO metabolism. Inhibition of KDO synthesis or incorporation into LPS leads to the accumulation of molecules which resemble lipid A in structure (7, 16, 23) . The biochemical and physiological consequences of such inhibition include (i) accumulation of lipid A derivatives in the inner membrane (15) , (ii) growth stasis (24) , (iii) translocation of lipid A derivatives to the outer membrane (15) , (iv) perturbation of outer membrane structure allowing insertion of the * Corresponding author. membrane attack complex of complement leading to cell death (R. Goldman and M. Miller, in preparation), and (v) avirulence in a mouse model system (R. Goldman, unpublished data).
A study of early steps in the assembly of LPS in Escherichia coli began from the fortuitous isolation of a mutant defective in formation of the basic disaccharide structure of lipid A (14) . UDP-N-acetylglucosamine is routed to LPS synthesis when it is acylated with ,-hydroxymyristic acid by a specific acylase (1) to yield UDP-2,3-diacyl-glucosamine. A portion of UDP-2,3-diacyl-glucosamine is hydrolyzed to yield free 2,3-diacyl-glucosamine, which can be condensed with UDP-2,3-diacyl-glucosamine to yield the basic lipid A disaccharide structure (20) , which is then phosphorylated at the 4' position (21) .
We have developed a new class of antibacterial agents which specifically inhibit KDO incorporation into LPS in gram-negative bacteria (5). These new antibacterial agents consist of a KDO analog, a-C-(1,5-anhydro-7-amino-2,7-dideoxy-D-manno-heptopyranosyl)carboxylate (II), attached via amide linkage to the C terminus of alanylalanine (Fig. 1 harvested and washed twice with 10 ml of 0.01 M HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid)-NaOH buffer (pH 7.4), and cell pellets were suspended in 1.25 ml of methanol containing 0.1 N HCI; 0.5 ml of H20 and 0.625 ml of chloroform were then added. The 0.5 ml of H20 contained 1 mg (dry weight) of RG109 cells which had been shifted to 42°C for 3 h to induce accumulation of lipid A derivatives. Samples were mixed intermittently at room temperature for 20 min, phases were separated by centrifugation at 5,000 x g for 5 min, and the lower chloroform phase was saved. Chloroform (1.25 ml) was added to the methanol phase and interface, and the solution was then mixed and centrifuged. The first and second chloroform phases were combined and dried under a stream of N2. The residue was resuspended in chloroform for application to Silica Gel H plates (250 ,um; Analtech). Plates were developed in a solvent of chloroform, pyridine, 88% formic acid, and H20 (40:60:16:5) for 2 h and air dried. Fractions (0.5 cm) were scraped into scintillation vials, and radioactivity was determined after the addition of 100 ,ul of H20, followed by 10 ml of Instagel (Packard Instrument Co., Inc.).
The potential degradative effects of extraction on lipid A derivatives from E. coli PL2 were examined as follows. Cells treated with III were radiolabeled with N-[3H]acetylglucosamine and extracted as described above. A portion of the chloroform phase (0.5 ml) was removed for thin-layer chromatography while the remainder (about 1.5 ml) was evaporated to dryness under nitrogen, and carrier cells (equivalent to 2 ml of cells treated with III, but unlabeled) were added. This cycle was repeated, and the precursor from each cycle was analyzed by thin-layer chromatography.
Purification of lipid A derivatives. S. typhimurium LT2 strain RG111 and E. coli PL2 were grown overnight at 37°C in MOPS plus 0.2% glucose. The next day, 2 to 4 liters of fresh medium containing 0.5 mM N-acetylglucosamine was inoculated to an A420 of 0.1 and incubated at 37°C in a shaker bath until an A420 of 0.4. Peptide prodrug III was added to a final concentration of 50 pug/ml, followed by 50 ,uCi of N-acetyl-D-[1-3Hlglucosamine (2.8 Ci/mmol). Incubation was continued at 37°C for 3.5 h. Cultures were harvested by centrifugation, and the pellet was washed twice with cold 50 mM HEPES buffer (pH 7.6). Pellets were stored at -20°C.
Cell pellets were delipidated by a series of extractions with 95% ethanol, followed by acetone and then diethyl ether (22) . Delipidated cells were extracted several times in phenol-chloroform-petroleum ether (2:5:8), and the extract was evaporated under nitrogen to the phenol phase. The phenol phase was loaded onto a 2.5 by 11 cm DEAE-cellulose column equilibrated with 99% methanol containing 1% acetic acid. The column was washed with equilibration buffer and then eluted with a linear gradient (500 ml) of 0 to 1 M ammonium acetate in the buffer described above (12, 22) . Fractions (4 ml) were collected, and tritium counts for a portion of each fraction were determined with a Packard Tri-Carb 300 scintillation counter. Peak tubes were pooled and extracted into chloroform by using a modified BlighDyer procedure (14, 16) .
Analysis of lipid A derivatives. The fatty acid contents of chloroform extracts were determined by gas chromatography after conversion to methyl esters with methanolic HCl (2). The mass molecular ion (M -H)-of lipid A precursors was determined by negative fast atom bombardment mass spectroscopy on a Kratos MS-50 mass spectrometer (AEI/Kratos). Samples in 99% methanol were mixed with a matrix of thioglycerol-glycerol (1:1) or aminoglycerol-glycerol (1:1) on the instrument probe. A neutral beam of xenon was used, and the translation energy varied between 6 and 8 kV. Data were collected at a scan rate of 30 s per decade over a mass range of 160 to 1,600 daltons.
RESULTS AND DISCUSSION Accumulation of lipid A derivatives. The antibacterial agent III (Fig. 1) causes inhibition of LPS synthesis, inhibition of cell growth, and accumulation of lipid A derivatives in S. typhimurium LT2. The four major species which accumulated comigrated with the four major species accumulating when bacteria containing genes coding for temperaturesensitive enzymes of the KDO pathway (kdsA or kdsB) are shifted to the restrictive temperature (Fig. 2) . E. coli PL2 ceased growing, and two components similar to those in S. typhimurium accumulated after the addition of III (Fig. 2) . Both components from E. coli were radiolabeled with N- amino-2-deoxy-a-D-glucose, acylated at positions 2, 3, 2', and 3' with P-hydroxymyristoyl groups and bearing phosphates at positions 1 and 4' (16). The second more polar species from E. coli comigrated with species "',A of S. typhimurium (Fig. 2) , which is a derivative of IVA containing phosphoethanolamine attached to the 4' phosphate. The two other species from a kdsA mutant of S. typhimurium are designated 'A and IIA (16) . Species IA is identical to IVA except for the attachment of phosphoethanolamine to the 4' phosphate and aminopentose to the 1 phosphate (16). Species "A is identical to IVA except for the attachment of aminopentose to the 1 phosphate (16). We were concerned that the slower-migrating species from E. coli might be a degradation product of the faster-migrating species, since the extraction conditions were acidic. However, the slowermigrating species from E. coli is not a degradation product of the faster-migrating species, because the ratio of the two species remained constant during four passages through the extraction procedure (ratios of IVA/slower-migrating species were 1.8, 1.9, and 2.1 for the first, second, and third extraction cycles, respectively).
Purification and characterization of lipid A derivatives. Lipid A derivatives that accumulated during treatment with III were purified from both S. typhimurium LT2 (strain RG111) and E. coli PL2 (Fig. 3) . Cells (2 to 3 liters) were grown in MOPS medium and treated with 50 jig of III per ml.
Lipid A derivatives were extracted from delipidated cells and purified by chromatography on DEAE-cellulose col-30 umns (Fig. 3) . Materials designated peaks 1 and 2 ( Fig. 3) 
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were pooled for analysis. The molar ratio of glucosamine/ P-hydroxymyristic acid/phosphate was 1:2:1 for the peak 2 material isolated from both S. typhimurium and E. coli, which is in agreement with the compositional analysis of lipid A derivatives isolated from a kdsA mutant of S. 6 .2 ,umol of phosphate, giving the expected phosphate-tofatty acid ratio of 0.5). In contrast, peak 1 from S. typhimurium did contain glucosamine and BHMA (Table 1) , which represented 25% of the total applied. When examined by chromatography on Silica Gel H, peak 1 was enriched for species 1 to 3 and contained residual phospholipid, whereas peak 2 lacked phospholipid but was enriched for species 4 (IVA), which represented 80% of the total material.
Response of S. typhitnurium to various doses of IH. The response of S. typhimurium LT2 to III was dose related (Fig.  5 ). The addition of 25 ,ug/nml or more caused growth stasis, whereas the addition of smaller amounts either transiently affected growth (5 or 10 ,ug/ml) or showed no effect (1 ,ug/tnl). The accumulation of lipid A derivatives was also dose related, because the addition of 1, 5, 10, 25, 50, or 100 p.g of III per ml to 5-ml cultures of RG111 caused the accumulation of 900, 1,800, 3,900, 7,200, 17,100, and 16,500 cpm in lipid A derivatives, respectively, per 200 ,ug of cell protein.
The transient inhibition of growth at doses below 25 ,ug/ml is likely due to an increase in the intracellular concentration of free KDO. The inhibitor released from III is an analog of KDO which acts as a competitive inhibitor of CMP-KDO synthetase (Ki = 3 R,M). Such inhibition would directly block the utilization of KDO but not its synthesis, a situation which should cause an increase in the intracellular level of KDO. The degree of increase in KDO concentration may be quite extensive, since the enzymes involved in KDO synthesis are apparently insensitive to feedback repression by their reaction products (17, 18, 19) . Diazaborine was initially reported to be a specific inhibitor of transfer of KDO from CMP-KDO to lipid A precursor (8) General conclusions. The early steps in the assembly of LPS are similar in S. typhimurium and E. coli. Inhibition of KDO incorporation at the site of CMP-KDO synthetase leads to rapid accumulation of precursor species IVA, followed by a slower and less extensive accumulation of more polar species. Aminopentose has never been reported as a constituent of E. coli LPS, and precursor species comigrating with IA and ",A of S. typhimurium (which contain aminopentose) were not observed in the present study. We conclude that species IVA is likely the normal acceptor of KDO in both S. typhimurium and E. coli and that the differences in secondary accumulation of more polar precursor species simply reflects species-specific differences in steps which normally occur following the addition of KDO.
LITERATURE CITED
